Efficacy and safety of COX 2 inhibitors -: New data are encouraging but the risk:benefit ratio remains unclear

被引：18

作者：

Jones, R ^{[1
]}

机构：

[1] Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7365期

关键词：

D O I：

10.1136/bmj.325.7365.607

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：607 / 608

页数：2

共 11 条

[1] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[2]

BUDENHOLZER BR, 2002, BMJ 0902

[3] Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials [J].

Deeks, JJ ;

Smith, LA ;

Bradley, MD .

BRITISH MEDICAL JOURNAL, 2002, 325 (7365) :619-623

[4]

Husain SS, 2002, AM J GASTROENTEROL, V97, P542

[5] Are selective COX 2 hihibitors superior to traditional non steroidal anti-inflammatory drugs?: Adequate analysis of the CLASS trial indicates that this may not be the case [J].

Jüni, P ;

Rutjes, AWS ;

Dieppe, PA .

BRITISH MEDICAL JOURNAL, 2002, 324 (7349) :1287-1288

[6] Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs [J].

Mamdani, M ;

Rochon, PA ;

Juurlink, DN ;

Kopp, A ;

Anderson, GM ;

Naglie, G ;

Austin, PC ;

Laupacis, A .

BRITISH MEDICAL JOURNAL, 2002, 325 (7365) :624-627

[7]

*NAT I CLIN EXC, 2001, GUID US CYCL COX 2 S

[8] COX-2, prostanoids and colon cancer [J].

Ota, S ;

Bamba, H ;

Kato, A ;

Kawamoto, C ;

Yoshida, Y ;

Fujiwara, K .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 :102-106

[9] Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial [J].

Silverstein, FE ;

Faich, G ;

Goldstein, JL ;

Simon, LS ;

Pincus, T ;

Whelton, A ;

Makuch, R ;

Eisen, G ;

Agarwal, NM ;

Stenson, WF ;

Burr, AM ;

Zhao, WW ;

Kent, JD ;

Lefkowith, JB ;

Verburg, KM ;

Geis, GS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10) :1247-1255

[10]

VITRY AI, 2002, BMJ 0902

← 1 2 →